Stockscreener 앱 받기
99.52
4.15%
-4.31
전일 마감가:
$103.83
열려 있는:
$102.71
하루 거래량:
1.59M
Relative Volume:
1.07
시가총액:
$11.28B
수익:
$2.77B
순이익/손실:
$286.61M
주가수익비율:
42.35
EPS:
2.35
순현금흐름:
$524.11M
1주 성능:
-8.27%
1개월 성능:
-2.49%
6개월 성능:
+12.22%
1년 성능:
-18.67%
1일 변동 폭
$98.89
$104.61
1주일 범위
$98.89
$109.29
52주 변동 폭
$81.36
$123.34
퍼킨엘머 Stock (RVTY) Company Profile
명칭
Revvity Inc
전화
781-663-6900
주소
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, IQV
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
99.52 | 11.77B | 2.77B | 286.61M | 524.11M | 2.35 |
|
TMO
Thermo Fisher Scientific Inc
|
542.36 | 212.36B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
215.75 | 155.19B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
643.59 | 51.34B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
129.64 | 37.70B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
180.96 | 34.49B | 15.90B | 1.28B | 2.21B | 7.2842 |
퍼킨엘머 Stock (RVTY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Goldman | Neutral |
| 2025-10-16 | 개시 | Guggenheim | Neutral |
| 2025-05-01 | 업그레이드 | UBS | Neutral → Buy |
| 2025-01-10 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Equal Weight |
| 2024-07-08 | 개시 | Leerink Partners | Outperform |
| 2024-06-03 | 재개 | Jefferies | Hold |
| 2024-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-12-19 | 개시 | Wells Fargo | Equal Weight |
| 2023-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-05-23 | 재개 | Goldman | Buy |
모두보기
퍼킨엘머 주식(RVTY)의 최신 뉴스
Revvity unveils new high-impact discovery platforms and showcases recent innovations at SLAS2026 - News-Medical
Momentum Shift: Is Revvity Inc impacted by rising ratesQuarterly Earnings Report & Short-Term High Return Ideas - baoquankhu1.vn
Revvity (RVTY) Deepens AI And Buybacks Strategy: Is Diagnostics Now Its Core Value Engine? - simplywall.st
Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Yahoo Finance
Revvity (RVTY) Receives a Buy from UBS - The Globe and Mail
Behavioral Patterns of RVTY and Institutional Flows - Stock Traders Daily
Revvity Inc.: How a Quiet Lab-Tech Powerhouse Is Rewiring the Future of Diagnostics and Drug Discove - AD HOC NEWS
Cowen & Co. Maintains Hold on Revvity (RVTY) Feb 03, 2026 - Meyka
Revvity stock price target raised to $124 from $120 at TD Cowen - Investing.com Canada
Revvity stock rating reiterated at Overweight by KeyBanc By Investing.com - Investing.com South Africa
JPMorgan Chase & Co. Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY S - GuruFocus
Revvity: Close To A Buy, Not Quite There (NYSE:RVTY) - Seeking Alpha
How is Revvity's stock performance compared to other health care stocks? - MSN
Revvity (NYSE:RVTY) Shares Track S&P 500 as Index Benchmarks Hold - Kalkine Media
Here's Why Revvity (RVTY) is a Strong Momentum Stock - sharewise.com
Revvity stock price target raised to $124 from $120 at TD Cowen By Investing.com - Investing.com India
TD Cowen Maintains 'Buy' Rating on RVTY, Raises Price Target to $124 | RVTY Stock News - GuruFocus
Revvity (NYSE:RVTY) Stock Price Expected to Rise, TD Cowen Analyst Says - MarketBeat
Transcript: Q 2026 Earnings Conference Call - Benzinga
Revvity (RVTY) Receives Price Target Boost from Evercore ISI Gro - GuruFocus
Barclays Maintains Overweight Rating on RVTY, Raises Price Targe - GuruFocus
Wells Fargo Raises Price Target for RVTY, Maintains Equal-Weight Rating | RVTY Stock News - GuruFocus
Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
Revvity stock rating reiterated at Overweight by KeyBanc - Investing.com Canada
Wells Fargo & Company Issues Positive Forecast for Revvity (NYSE:RVTY) Stock Price - MarketBeat
Revvity (RVTY) Maintains Hold Rating, Price Target Raised to $10 - GuruFocus
Wells Fargo Adjusts Price Target on Revvity to $110 From $107 - marketscreener.com
TD Cowen Adjusts Revvity PT to $124 From $120 - marketscreener.com
Revvity, Inc. (NYSE:RVTY) Q4 2025 earnings call transcript - MSN
Revvity, Inc. (NYSE:RVTY) Q4 2025 Earnings Call Transcript - Insider Monkey
Baird Adjusts Price Target on Revvity to $129 From $123 - marketscreener.com
Raymond James Adjusts Price Target on Revvity to $132 From $115 - marketscreener.com
Evercore ISI Adjusts Price Target on Revvity to $118 From $112 - marketscreener.com
Barclays Adjusts Price Target on Revvity to $118 From $115 - marketscreener.com
Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter - WHTC
Fund Flows: Whats the beta of Revvity Inc stockMarket Sentiment Summary & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Revvity Q4 2025 slides: EPS beats expectations, stock dips despite strong results - Investing.com Nigeria
Revvity Earnings Call: Solid Execution, Cautious 2026 Outlook - TipRanks
Is Revvity (RVTY) Attractive After Recent Share Price Weakness And DCF Valuation Gap - Yahoo Finance
Revvity: Q4 Earnings Snapshot - KHOU
Revvity Q4 2025 Earnings Call Transcript - MarketBeat
Revvity shares tick up after fourth-quarter results and guidance update - AlphaStreet
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic ... By GuruFocus - Investing.com Canada
Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic Growth Initiatives - GuruFocus
Revvity, Inc. Provides Revenue Guidance Full Year of 2025 - marketscreener.com
Evercore ISI Raises Revvity Price Target to $118 From $112 - marketscreener.com
Revvity Q4 Earnings Call Highlights - Yahoo Finance
Revvity shares edge higher after fourth-quarter earnings and full-year update - AlphaStreet
Revvity's (NYSE:RVTY) Q4 CY2025 Sales Beat Estimates - Finviz
Revvity (NYSE:RVTY) Shares Track S&P 500 After Corporate Update - Kalkine Media
퍼킨엘머 (RVTY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
1.94%
자본화:
|
볼륨(24시간):